ASCRS

ICYMI: Frank W. Bowden, III, MD, FACS shares the take-home message from his 2019 ASCRS presentation. Check it out below!

Eva Liang, MD, discusses the take-home message from her presentation at ASCRS 2019

ICMYI: Dr. Tyson shares his pearls using the dexamethasone 0.4 mg insert (Dextenza, Ocular Therapeutix).

ICYMI: Dr. Shultz shares the results from a study comparing dual linear venturi phacoemulsification with adaptive fluidics systems using femtosecond-assisted grid pattern versus traditional phaco with horizontal chop

Robert Maloney, MD, shares how a novel system can assist refractive surgeons

Bausch + Lomb provides a company update at the 2019 ASCRS meeting. 

Here's why John Sheppard, MD, believes nutrition should be the cornerstone of dry eye therapy.

When used in supplement with other dry eye treatments, patients see improvement

Here's the latest innovations at Neurotech Pharmaceuticals, Inc. 

Selective laser trabeculoplasty (SLT) could be an affordable option for glaucoma management, according to Nathan Radcliffe, MD. 

Dr Jacqueline Beltz, FRANZCO, shares the take-home message from her 2019 ASCRS presentation

Topical drug for the treatment of dry eye disease sees potential 

E. Randy Craven, MD, shares results from a phase 1/2 study involving an intracameral bimatoprost sustained-release implant. 

Laura M. Periman, MD, shares how IPL therapy can quickly rid patients of painful chalazions

Audrey Talley Rostov, MD, discusses corneal cross-linking (CXL) complications, and when to consider CXL treatment 

Retina specialist Ron M. Kurtz, MD, details the way collaborative innovation can improve the lives of ophthalmic surgeons, and their patients.

Patients prefer the convenience of using a compounded triple combination drop over a standard medication plan.

Procedure may be a promising option for presbyopia correction in emmetropic patients, according to results of clinical trial presented by Aylin Kiliç, MD, at ASCRS 2019.

A technique to assure complete separation of the cap and prevent a radial tear has been perfected by Steve Arshinoff, MD. 

Sara Anastas, MD, discusses criteria for surgical intervention methods with either corneal crosslinking (CXL) or penetrating keratoplasty in pediatric patients.

Providing findings from a retrospective study, Li Lim, MD, noted that eyes with high myopia benefit from CXL add-on to LASIK, resulting in safety, efficacy, and predictability with refractive outcomes that are more stable than those achieved with LASIK alone. 

The registry provides real-world evidence of safety, and durable efficacy of a glaucoma surgery device.  

Stephen C. Pflugfelder, MD, honored as the recipient of the Binkhorst Lecture and medal at ASCRS 2019, lectured on the quest for tear stability in dry eye patients. 

New technology offers surgeons the unfolding efficiency of an enhanced material along with the rotational stability that characterizes the current toric platform. 

Corneal surgery for Fuchs’ rejuvenates the endothelium rather than replacing it, and DSO is joining the lineup as a new treatment option.

During Refractive Day at ASCRS 2019, Julie Schallhorn, MD, MS, shed some new light on the topic by challenging conventional wisdom about dry eye and LASIK. 

A carefully packed surgical toolkit can optimize cataract surgery outcomes.

The 2019 annual meetings of the American Society of Cataract and Refractive Surgery and the American Society of Ophthalmic Administrators will be held May 3 to 7 in San Diego.

With ability to provide LASIK-like outcomes, the light-adjustable lens creates a new opportunity for cataract surgeons to grow the premium channel, says Fritz H. Hengerer, MD, PhD.

Favorable outcomes have been achieved after the first clinical use of IOL technology that is designed to maintain an open capsule long-term after cataract surgery and enable refractive fine-tuning postoperatively.